- CSR in Takeda
- Support for Areas Affected by the Great East Japan Earthquake
- CSR Activities and Targets
- ISO 26000 Core Subjects
- Organizational Governance
- Human Rights
- Labor Practices
- The Environment
- Fair Operating Practices
- Consumer Issues
- Community Involvement and Development
- Policies
- Reports
- CSR Data Book Survey
>NEWSROOM
>April - June 2008
>Notice of Execution of Acquisition of the Company's Own Shar...
April - June 2008
June 24, 2008
Takeda Pharmaceutical Company Limited
Notice of Execution of Acquisition of the Company's Own Shares
Osaka, Japan, June 24, 2008 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on May 9, 2008.
| 1. Class of shares acquired: | Shares of common stock |
|---|---|
| 2. Period of acquisition: | From May 12, 2008 to June 20, 2008 |
| 3. Total number of shares acquired: | 16,994,200 shares |
| 4. Total value of acquisition: | Yen 99,999,796,000 |
| 5. Method of acquisition: | Purchased on the Tokyo Stock Exchange |
(Reference)
Resolution of the Board of Directors on May 9, 2008
| 1. | Class of shares to be acquired: | Shares of common stock |
| 2. | Number of shares to be acquired: | Up to 18 million shares |
| (equivalent to 2.02% of the total issued shares) | ||
| 3. | Total amount of shares to be acquired: | Up to 100 billion Yen |
| 4. | Schedule of acquisition: | From May 12, 2008 to June 23, 2008 |
Treasury shares held by Takeda as of June 23, 2008
| 1. Aggregate number of issued shares: (excluding treasury shares) |
814,946,978 shares |
| 2. Number of treasury shares: | 17,195,417 shares |
# # #
Latest News Release
Copyright © 1995-2013 Takeda Pharmaceutical Company Limited. All rights reserved.